Paxil (paroxetine), a selective serotonin reuptake inhibitor (SSRI), and creatine have different pharmacological profiles, but recent research highlights potential synergies and clinical considerations when they are used together. Therapeutic Augmentation and Synergy
: In a double-blind trial involving women with major depressive disorder, creatine augmentation (5 g/day) of an SSRI led to significantly greater improvements in Hamilton Depression Rating Scale (HAM-D) scores as early as week 2 compared to placebo. Paxil And Creatine
: Evidence from animal models indicates that creatine may interact with the serotonergic system, potentially enhancing the efficacy of medications like Paxil. Clinical Monitoring and Safety a selective serotonin reuptake inhibitor (SSRI)